Large-scale testing (Phase 3)WithdrawnNCT00226512
What this trial is testing
To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity Conditioning
Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Hadassah Medical Organization 203